Showing posts with label daVIZta. Show all posts
Showing posts with label daVIZta. Show all posts

Thursday, July 31, 2014

How to Address Commercial Ops, Commercial Contracting and Government Pricing


At MDRP 2013, Mark Linver, Director, Huron Life Sciences discusses addressing government and commercial pricing operations during mergers and divestitures. Below are two highlighted sessions from MDRP 2014 that will look into Commercial Ops, Commercial Contracting and Government Pricing.


Session Highlight:
Spillover Effects Between Government Pricing, Commercial Business & Contracting Strategies

• Discuss healthcare reforms impact on contracting & emerging contracting practices
• Evaluate the impact of government pricing changes on commercial accounts
• Reevaluate and restructure rebate and discount agreements

David Chan, Practice Leader, Compliance & Audit, Managed Markets Services, IMS Health


Session Highlight:
Improving Effectiveness of Revenue Analytics by Using GP Forecasting

The continual growth of the government channel has increased the importance of understanding the cross-channel impact of the commercial pricing and contracting decisions that drive liabilities. Along with increasing pressure to understand, forecast and accurately accrue for revenue line items as part of the GTN process, an expanding government channel means contracting and pricing functions have a greater need for pricing and forecasting outputs from the GP department. The “modern” GP team is tasked with providing “what if” analyses and forecasts for a wide variety of company specific and industry wide events, and is looked upon as a critical resource when pricing and contracting decisions are being made. Today’s GP team must be adept at developing quick yet sophisticated models to assess how any given event may affect Revenue lines that are driven by a Government payer.

This session will take a look at how to effectively incorporate commercial strategies and market events into the forecast of GP price points. We will explore how to:

• Manage and align data for analytical needs
• Consider price increases and commercial contracting strategies
• Incorporate channel shifts into forecasts
• Evaluate regulatory and market events in scenario modeling
• Identify what you know and what you don’t know, and how both should be considered and modeled

Jeffrey Baab, Senior Director, Life Sciences, daVIZta





Register by Friday 8/8 to save $300! Make sure you use the code XP1958BLOG | Register Now!




Thursday, April 3, 2014

Reminder - Complimentary Revenue Leakage Webinar | Register Now


Revenue Leakage:  Industry Definition, Insight and Best Practices to Mitigate Risk
Join us for a Webinar on April 14th—space is limited!
Reserve your Webinar seat here.
Mention Priority Code: XP1911WEB

Understand what ‘Revenue Leakage’ means to branded pharma, start-ups, generics, and biotechs with IIR’s 2nd Annual Gross-to-Net Accounting Forum’s discussion group chairs! 
• Collective Industry Definition
• Customer Segment and Channel impacts
• Financial Statement impacts (accruals, cash flow, forecasting)
• The industry risk between adjudication and audit —the need for continuous improvement.
• Industry best practices and next steps for mitigating risk and continuous improvement.   

MODERATOR:
Jennifer Sharpe, Revenue Analytics Gross-to-Net, daVIZta

PRESENTERS:
From Big Pharma – Courtney Callihan, Finance Director, GlaxoSmithKline
From Small to Mid-Sized Pharma – Larry Breen, Director of Financial Planning and Analysis/Revenue Analytics, Sunovion Pharmaceuticals
From Generics – Roxana Santiago, Senior Finance Director, Gross to Net, Hospira Worldwide, Inc.

After registering you will receive a confirmation email containing information about joining the Webinar.

Keep the discussion going with our Chairs at IIR's 2nd Annual Gross-To-Net Accounting Forum

2014 Conference Highlights include:
• New tailored discussion groups to collaborate across Managed Markets, Commercial, Government Programs and Finance for Big, Small to Mid-Sized Pharma, and Generics
• First opportunity to get up close and personal with the AMP Final Rule at the pre-conference workshop
• Never-before-heard case studies on GTN automation and chargeback methodology, in addition to strategic forecasting panel discussions
• Quantifying approaches for the impact of Medicaid, 340B and Healthcare Reform

Register by 5/2 and save up to $400 off standard registration rates

If you have any questions about the agenda or event, please contact Ryan Geswell at rgeswell@iirusa.com or visit our webpage.

We look forward to seeing you June 17-18 in Philadelphia!


Opt-in for updates

Follow us on Twitter
Enhanced by Zemanta